2 news items
Zymeworks Appoints Leone Patterson as Chief Business and Financial Officer
25 Jul 24
company biotech experience with a proven track record of guiding strategy, finance, operations, and governance through multiple phases of growth, planning
Zymeworks Announces FDA Clearance of Investigational New Drug Application for ZW171, a novel 2+1 T-cell Targeting Bispecific Antibody for Mesothelin-expressing Cancers
17 Jun 24
to initiating clinical development of ZW171 during 2024 and continuing to advance additional product candidates in our ‘5 by 5' strategy over the next 24
- Prev
- 1
- Next